Reviews on novel hormonal agents and strategies for sequencing of various therapies seek to provide a good understanding of this dynamic area of research in prostate cancer. We have enjoyed editing this series and have ourselves learned a lot from the excellent articles. We hope you will likewise find them helpful in furthering your understanding of prostate cancer and for your clinical practice.
Editorial on Current and Future Topics on Prostate Cancer
Preface to “Current and Future Topics on Prostate Cancer”
Review Article on Current and Future Topics on Prostate Cancer
Biomarkers for detection of clinically significant prostate cancer: contemporary clinical data and future directions
Epigenetics in prostate cancer: clinical implications
MRI/PET Imaging in elevated PSA and localized prostate cancer: a narrative review
Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: a narrative review
Focal therapy for primary and salvage prostate cancer treatment: a narrative review
Original Article on Current and Future Topics on Prostate Cancer
Subtotal surgical therapy for localized prostate cancer: a single-center precision prostatectomy experience in 25 patients, and SEER-registry data analysis
Review Article on Current and Future Topics on Prostate Cancer
Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review
Narrative review of management strategies and outcomes in node-positive prostate cancer
Rapidly evolving treatment paradigm and considerations for sequencing therapies in metastatic prostate cancer—a narrative review
Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice
Disclosure:
The focused series “Current and Future Topics on Prostate Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Badrinath Konety and Daniel W. Lin served as the unpaid Guest Editors for the focused series.